This webinar is jointly provided by CancerNet, LLC. and Amedo, LLC.
This activity is supported in part by an independent education grant from Merck Sharp & Dohme Corp.
This activity will cover topics on the diagnosis, treatment, and management of patients with colorectal cancer. Upon completion of this activity, participants should be better able to:
This activity is designed to meet the educational needs of gastroenterologists, medical oncologists, radiation oncologists, surgeons, physician assistants, nurse practitioners, nurses, and healthcare professionals involved in the treatment of colorectal cancer patients.
Date and Time:
This webinar will be held on:
Axel Grothey, MD
Director, GI Cancer Center Research
West Cancer Center & Research Institute
Michael A. Morse, MD, FACP, MHS
Professor of Medicine
Professor in the Department of Surgery
Duke Cancer Institute
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and CancerNet. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™ for physicians and 1.25 hours for nurses. Learners should claim only the credit commensurate with the extent of their participation in the activity.
Planners and Managers
Instructions for Participation and Credit
There are no fees for participating and receiving CME/CE credit for this enduring activity. To receive CME/CE credit participants must:
Certificates will be emailed to the participant.
Disclosure of Unlabeled Use
CancerNet and Amedco require that faculty participating in any CME/CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Amedco makes every effort to develop CME/CE activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME/CE questions, please contact: Amedco at: email@example.com
For questions regarding the content, please contact: CancerNet at firstname.lastname@example.org